Non-invasive MSOT Examination of Muscle Oxygenation in Athletes and PAD Patients

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorUniversity Hospital Erlangen

About this trial

The aim of the study is to present the quantitative differences in oxygenated hemoglobin in different cohorts.

This clinical study evaluates whether there is a correlation between measurements using multispectral optoacoustic tomography and the results of spiroergometry in the context of performance diagnostics.

Eligibility criteria

Qualifiers

Age ≥ 18 years (adults capable of giving consent)

Capacity to consent. The subjects are able to understand the information provided and give their written consent.

Endurance athletes: at least 3× per week ≥ 60 minutes of intensive endurance training (e.g., running, cycling, swimming)

Strength athletes: at least 3× per week ≥ 60 minutes of intensive strength training without additional endurance training

Disqualifiers

Age over 75 years

Minors (Age < 18)

safety concerns on the part of the study physician, e.g., in the case of of: physical, mental or psychiatric illnesses, acute or chronic conditions that could jeopardise safety or data quality

Taking medications that could affect physical performance or physiological measurements (e.g., heart rate, oxygen uptake).

Trial design

Treatments tested in this trial

  • MSOT - Multispectral optoacustic tomography
  • CPET

Treatment groups

60 Participants
are divided into 6 treatment groups

6

Treatment groups

See each treatment group below.

Locations

This trial has no locations

Sponsors and collaborators

University Hospital Erlangen

Lead sponsor

PD Dr. med. Ferdinand Knieling, Department of pediatrics, University of Erlangen-Nürnberg

Collaborator